Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07247994

Neurological Manifestations in Children Diagnosed With Inflammatory Bowel Disease

screen for neurologic and psychiatric disorders in children and

adolescents with IBD.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

About this study

Neurologic symptoms have a great importance in early diagnosis and

treatment preventing major morbidity and later sequelae, especially if they

precede GI symptoms

The prevalence of neurologic manifestations of IBD varies between 0.2% and

36%. Their pathogenesis of neurologic manifestations in IBD consists of 6

mechanisms: 1.malabsorption and nutritional deficiency 2.metabolic agents

3.infections complicating immune suppression 4.side effects of medications or

iatrogenic as a surgical complication 5.thromboembolism 6.immunological

factors

UC patients are similar to or higher than CD patients in the probability of

neurologic symptoms. Neurologic manifestations and complications include:

headache, dizziness, hypotonia, ADHD, tics, sensory complaints, seizures,

neuropsychiatric disorders, peripherial neuropathy, meningitis, vestibular

dysfunction, idiopathic IC hypertension, cerebral vasculitis, demyelinating

disorders and migraine

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • patients with IBD aged from from 1 to18 years old.

Exclusion criteria

  • patients with IBD and aged above 18 years old or below 1 year old

Treatment and study plan

Primary outcomes

  1. Screening for Neurological manifestations among children diagnosed with inflammatory bowel disease in Assiut university children hospital

    Time frame: during the period from January 2026 to January 2027.

    Neurologic symptoms have a great importance in early diagnosis and

    treatment preventing major morbidity and later sequelae, especially if they

    precede GI symptoms

    The prevalence of neurologic manifestations of IBD varies between 0.2% and

    36%. Their pathogenesis of neurologic manifestations in IBD consists of 6

    mechanisms: 1.malabsorption and nutritional deficiency 2.metabolic agents

    3.infections complicating immune suppression 4.side effects of medications or

    iatrogenic as a surgical complication 5.thromboembolism 6.immunological

    factors

    UC patients are similar to or higher than CD patients in the probability of

    neurologic symptoms. Neurologic manifestations and complications include:

    headache, dizziness, hypotonia, ADHD, tics, sensory complaints, seizures,

    neuropsychiatric disorders, peripherial neuropathy, meningitis, vestibular

    dysfunction, idiopathic IC hypertension, cerebral vasculitis, demyelinating

    disorders and migraine

  2. screen for neurologic and psychiatric disorders in children and adolescents with IBD.

    Time frame: 1 year

Study contacts

Contact information is provided by the study sponsor or research team.

Bishoy Shehata Faheem, Resident doctor

CONTACT

[email protected]

+201551312246

Sponsors and collaborators

Lead sponsor

Bishoy Shehata Fahim

Other

Registry information

Official study title

Neurological Manifestations in Children Diagnosed With Inflammatory Bowel Disease in Assiut University Child Hospital

Important dates

Study start
2026
Primary completion
2027
Study completion
2027
First posted
Nov 25, 2025
Registry last updated
Nov 25, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.